Earnings release
Page 1
amwell Amwell® Announces Results for Third Quarter 2021 • Revenue of $ 62.2 million in the third quarter Gross margins of 43 % of revenue compared to 33 % last year Exhibit 99.1 Total visits of 1.4 million Total active providers of approximately 80,000 at the end of the third quarter versus 71,000 last quarter and 62,000 last year Converge platform development and implementation on track BOSTON , November 10 , 2021 / BusinessWire / - Amwell® ( NYSE : AMWL ) ( the " Company " ) , a national telehealth leader , today announced financial results for the third quarter ended September 30 , 2021 . " In the third quarter , we were pleased to see further acceleration of user adoption and use case expansion on the Amwell platform . This was demonstrated by strong growth in active providers and recurring consumer visits . The transition to Converge is moving forward well . The addition of ConversaⓇ Health and SilverCloud® Health further enhances our differentiation as a single , digital care delivery platform designed to serve the full care spectrum across physical , virtual and automated modalities . We were thrilled to see so many existing and new clients and partners already commit to Converge as their long - term platform , ” said Dr. Ido Schoenberg , Chairman and CEO . Dr. Schoenberg continued , " Together with our clients and partners , we can now offer consumers a highly intuitive , fully integrated , cohesive healthcare experience . It features a hybrid combination of digital first capabilities with strong ties to traditional and trusted care pathways . Finally , it is apparent that our ability to contain and embed a whole spectrum of third party innovative apps , modules and programs will further solidify Amwell as a dependable , future ready choice for providers , payers and innovators . " Third quarter 2021 Financial Highlights : All comparisons , unless otherwise noted , are to the three months ended September 30 , 2020 . Total Revenue was $ 62.2 million , compared to $ 62.6 million • Subscription revenue was $ 26.7 million , compared to $ 25.8 million • Visit revenue was $ 30.0 million , compared to $ 28.5 million Gross margin was 43.5 % , compared to 32.7 % • Net loss was ( $ 50.9 ) million , compared to ( $ 64.6 ) million • Adjusted EBITDA was ( $ 31.5 ) million , compared to ( $ 26.2 ) million Total active providers were ~ 80,000 , compared to ~ 71,000 last quarter The addition of all 9,000 new active providers came from clients adding their own providers to the Amwell platform Total visits were ~ 1.4 million , compared to ~ 1.3 million last quarter